Akkermansia muciniphila in Metabolic Disease: Far from Perfect
Oana Laura Mierlan, Camelia Busila, Octavian Amaritei, Dogaru Elena, Cosmin Raducu Raileanu, Nicoleta-Maricica Maftei, Madalina Nicoleta Matei, Gabriela Gurau · 2025
Read Akkermansia muciniphila in Metabolic Disease: Far from Perfect by Oana Laura Mierlan, Camelia Busila, Octavian Amaritei, Dogaru Elena, Cosmin Raducu Raileanu, Nicoleta-Maricica Maftei, Madalina Nicoleta Matei, Gabriela Gurau (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12691757.txt.
Description
Oana Laura Mierlan and co-authors give a sober review of a fashionable gut bacterium proposed as a metabolic therapy. Their 2025 narrative review covers Akkermansia muciniphila, a mucus-dwelling microbe linked to stronger gut walls, calmer inflammation, weight loss, and better insulin response. The review's subtitle warns the story is far from perfect.
The authors sort what is established from what is merely suggested. Benefits are consistent in rodents, and the bacterium makes helpful short-chain fatty acids and signaling proteins. But strains vary, human trials are scarce, and cause has been shown only in animals. Metabolic disease is common and costly, which fuels the hype. The review asks the field for human proof before clinics promise results.
Catalog record
| CREATOR | Oana Laura Mierlan, Camelia Busila, Octavian Amaritei, Dogaru Elena, Cosmin Raducu Raileanu, Nicoleta-Maricica Maftei, Madalina Nicoleta Matei, Gabriela Gurau |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 32 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |